BTIG Research Initiates Teva Pharmaceutical At Buy By: Benzinga via Benzinga July 07, 2015 at 08:20 AM EDT Analysts at BTIG Research initiated coverage on Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) with a Buy rating. The target ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR